Page last updated: 2024-08-21

oxazoles and octimibate

oxazoles has been researched along with octimibate in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (75.00)18.2507
2000's2 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abid, S; Grove, RI; Hartl, KS; Kowala, MC; Mazzucco, CE; Seiler, SM; Warr, GA1
Wise, H2
Brassard, CL; Federici, ME; Meanwell, NA; Romine, J; Seiler, SM1
Chan, HW; Ho, JK; Jones, RL; Lam, WL; Qian, YM; Wise, H; Wong, HN; Yim, AP1
Chow, KB; Wise, H1
Chow, KB; Kam, Y; Wise, H1
Chow, KB; Wise, H; Wong, YH1

Other Studies

8 other study(ies) available for oxazoles and octimibate

ArticleYear
Prostacyclin agonists reduce early atherosclerosis in hyperlipidemic hamsters. Octimibate and BMY 42393 suppress monocyte chemotaxis, macrophage cholesteryl ester accumulation, scavenger receptor activity, and tumor necrosis factor production.
    Arteriosclerosis and thrombosis : a journal of vascular biology, 1993, Volume: 13, Issue:3

    Topics: Animals; Aorta, Thoracic; Arteriosclerosis; Chemotaxis; Cholesterol Esters; Cricetinae; Epoprostenol; Hyperlipidemias; Imidazoles; Macrophages; Male; Membrane Proteins; Monocytes; Oxazoles; Phenoxyacetates; Receptors, Immunologic; Receptors, Lipoprotein; Receptors, Scavenger; Scavenger Receptors, Class B; Tumor Necrosis Factor-alpha

1993
The inhibitory effects of non-prostanoid prostacyclin mimetics on rat neutrophil function.
    Prostaglandins, leukotrienes, and essential fatty acids, 1996, Volume: 54, Issue:5

    Topics: Acetates; Animals; Calcium; Cell Aggregation; Cyclic AMP; Drug Design; Epoprostenol; Glyburide; Iloprost; Imidazoles; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oxazoles; Phenoxyacetates; Phosphodiesterase Inhibitors; Prostaglandins, Synthetic; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin

1996
[3-[4-(4,5-Diphenyl-2-oxazolyl)-5-oxazolyl]phenoxy]acetic acid (BMY 45778) is a potent non-prostanoid prostacyclin partial agonist: effects on platelet aggregation, adenylyl cyclase, cAMP levels, protein kinase, and iloprost binding.
    Prostaglandins, 1997, Volume: 53, Issue:1

    Topics: Acetates; Adenylyl Cyclases; Animals; Binding, Competitive; Cell Membrane; Cyclic AMP; Epoprostenol; GTP Phosphohydrolases; Humans; Iloprost; Imidazoles; Oxazoles; Phenoxyacetates; Platelet Aggregation Inhibitors; Protein Kinases; Rabbits; Rats

1997
Relaxant actions of nonprostanoid prostacyclin mimetics on human pulmonary artery.
    Journal of cardiovascular pharmacology, 1997, Volume: 29, Issue:4

    Topics: Acetates; Aged; Cardiovascular Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epoprostenol; Fatty Acids; Humans; Iloprost; Imidazoles; Indoles; Middle Aged; Muscle, Smooth, Vascular; Oxazoles; Phenoxyacetates; Platelet Aggregation Inhibitors; Prostaglandins, Synthetic; Pulmonary Artery; Receptors, Epoprostenol; Receptors, Prostaglandin; Structure-Activity Relationship; Vasoconstrictor Agents; Vasodilator Agents

1997
The effect of prostacyclin mimetics on neutrophil function.
    Advances in experimental medicine and biology, 1997, Volume: 407

    Topics: Acetates; Animals; Cell Aggregation; Cyclic AMP; Epoprostenol; Iloprost; Imidazoles; Isoquinolines; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oxazoles; Peritoneal Cavity; Phenoxyacetates; Pyrrolidinones; Rats; Rolipram; Second Messenger Systems; Sulfonamides

1997
The effect of non-prostanoid prostacyclin mimetics on cyclic AMP production by neuronal SK-N-SH cells.
    Advances in experimental medicine and biology, 1997, Volume: 433

    Topics: Acetates; Cell Line; Cyclic AMP; Epoprostenol; Humans; Iloprost; Imidazoles; Kinetics; Neuroblastoma; Neurons; Oxazoles; Phenoxyacetates

1997
Factors affecting prostacyclin receptor agonist efficacy in different cell types.
    Cellular signalling, 2001, Volume: 13, Issue:11

    Topics: Acetates; Adenylate Cyclase Toxin; Animals; CHO Cells; Cricetinae; Cyclic AMP; Dose-Response Relationship, Drug; Epoprostenol; Heterotrimeric GTP-Binding Proteins; Humans; Imidazoles; Oxazoles; Pertussis Toxin; Phenoxyacetates; Receptors, Epoprostenol; Receptors, Prostaglandin; Signal Transduction; Tumor Cells, Cultured; Type C Phospholipases; Virulence Factors, Bordetella

2001
Prostacyclin receptor-independent inhibition of phospholipase C activity by non-prostanoid prostacyclin mimetics.
    British journal of pharmacology, 2001, Volume: 134, Issue:7

    Topics: Acetates; Adenylyl Cyclases; Alprostadil; Animals; Cell Survival; CHO Cells; Cricetinae; Cyclic AMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epoprostenol; Iloprost; Imidazoles; Inositol Phosphates; Oxazoles; Phenoxyacetates; Pyridines; Receptors, Epoprostenol; Receptors, Prostaglandin; Transfection; Tritium; Type C Phospholipases

2001